300,000
Clinical Trial Records
60,000
Product/Candidates
50,000
Sponsor/Organisation
January 20,2023 06:16 AM
Novavax Covid-19 Vaccine Nuvaxovid Receives Manufacturing And Marketing Approval From Korean Ministry Of Food And Drug Safety As An Adult Booster
January 20,2023 06:14 AM
STADA Xbrane Get UK MHRA Marketing Approval For Ximluci Biosimilar Referencing Lucentis
January 19,2023 06:51 AM
First Patient Dosed In CANbridge Pharmaceuticals CAN103 Phase 2 Trial For The Treatment Of Gaucher Disease In China
January 19,2023 06:44 AM
Novavax Nuvaxovid COVID-19 Vaccine Approved In South Korea As An Adult Booster
January 19,2023 06:41 AM
ImmunOs Therapeutics Gets TGA Approval To Begin First-in-human Trial Of IOS-1002
January 20,2023 06:32 AM
Astellas To Present Positive Findings From Phase 3 SPOTLIGHT Trial Of Zolbetuximab During 2023 ASCO GI Cancers Symposium
January 19,2023 06:55 AM
SciSparc Receives Approval To Conduct Its Clinical Trial In Children With Autism Spectrum Disorder At The Soroka Medical Center
January 19,2023 06:42 AM
Phanes Therapeutics Anti-claudin 18.2 Antibody Patent Granted In The US
January 18,2023 05:05 AM
SciSparc Announces Additional Positive Results From The Third Part Of Clearmind Medicine Inc. Pre-Clinical Study For Cocaine Addiction Treatment
January 17,2023 06:00 AM
Ascletis Announces Dosing Of 4 Healthy Subjects Of The First Cohort In Multiple-Dose Escalation Phase I Clinical Trial Of Oral 3CLpro Inhibitor ASC11 For COVID-19
January 14,2023 05:01 AM
Fresh Tracks Therapeutics Announces Data From Pre-clinical Studies Of FRTX-02
January 06,2023 04:47 AM
Innovent Announces NMPAs Breakthrough Therapy Designation For IBI351 (KRAS G12C Inhibitor) As Monotherapy For Previous Treated Advanced Non-small Cell Lung Cancer
January 06,2023 04:36 AM
Sedana Medical Gets US FDA Fast Track Status For Isoflurane Via Sedaconda ACD-S Device For Sedation Of Mechanically Ventilated Patients In ICU Setting
January 04,2023 05:40 AM
Datar Cancer Genetics Gets US FDA Breakthrough Designation For Blood Test, TriNetra-Glio To Help Diagnose Brain Tumours
December 30,2022 04:46 AM
AB Sciences Masitinib Receives Orphan Drug Status From Swissmedic To Treat Amyotrophic Lateral Sclerosis
January 20,2023 06:22 AM
EVOQ Therapeutics And Amgen Expanding Collaboration
January 20,2023 06:12 AM
Hong Kong Science And Technology Parks Corporation Inks Strategic Collaboration With Roche
January 19,2023 06:38 AM
Marengo Asia Healthcare, Karkinos Healthcare Collaborate To Revolutionize Cancer Care In India
January 18,2023 04:58 AM
Alvotech, Fuji Pharma Expand Commercialization Partnership By Adding A New Biosimilar Candidate
January 17,2023 05:51 AM
CARsgen Therapeutics And Huadong Medicine Announce Collaboration Agreement For Zevorcabtagene Autoleucel In Mainland China
Clinical trials data Insight in all Regulated Market, which includes and not limited to US, EU, AUS & NZ, Japan, Canada & India.
Clinical trials data Insight on over 3,00,000 clinical trials from Phase 0 to IV across all indication includes, Orphan disease and Therapy Area.
Sponsor key contacts on over 50,000 companies along with its category as Large, Mid and Small companies for identifying licensing candidates.
Clinical trial data coverage of over 60,000 Molecules of all Regulated Markets.
Pipeline Analysis of Company.
Key Information to help CRO for Outsourcing Projects.
Molecules categorised as Biologics Vs. Small Molecules to hit the right target for Licensing candidates.
News Alerts on Deals, In-Licensing, Out-licensing, Clinical Trial Development of molecules, Safety and efficacy data.
Orphan drug designation insights on all candidates
Fast track & Breakthrough designation by regulatory body.
